Abstract
While the intent-to-treat (ITT) analysis is widely accepted for superiority trials, there remains debate about its role in non-inferiority trials. It is often said that the ITT tends to be anti-conservative in the demonstration of non-inferiority. This concern has led to some reliance on per-protocol (PP) analyses that exclude patients on the basis of post-baseline events, despite the inherent bias of such analyses. We compare ITT and PP results from antibiotic trials presented to the public at the FDA's Anti-infective Drug Advisory Committee from 1999 to 2003. While the number of available trials is too small to produce clear conclusions, these data did not support the assumption that the ITT would lead to smaller treatment difference than the PP, in the setting of antibiotic trials. Possible explanations are discussed.
Keywords
Protocol (science)AntibioticsMedicineStatisticsComputer scienceMathematicsAlternative medicineBiologyPathology
Affiliated Institutions
Related Publications
Unpublished rating scales: A major source of bias in randomised controlled trials of treatments for schizophrenia
Background A recent review suggested an association between using unpublished scales in clinical trials and finding significant results. Aims To determine whether such an associ...
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
In a phase 2 trial, lenvatinib, an inhibitor of VEGF receptors 1-3, FGF receptors 1-4, PDGF receptor α, RET, and KIT, showed activity in hepatocellular carcinoma. We aimed...
From local explanations to global understanding with explainable AI for trees
Tree-based machine learning models such as random forests, decision trees, and gradient boosted trees are popular non-linear predictive models, yet comparatively little attentio...
Seventy-Five Trials and Eleven Systematic Reviews a Day: How Will We Ever Keep Up?
When Archie Cochrane reproached the medical profession for not having critical summaries of all randomised controlled trials, about 14 reports of trials were being published per...
Hepatocellular carcinoma
Liver cancer remains a global health challenge, with an estimated incidence of >1 million cases by 2025. Hepatocellular carcinoma (HCC) is the most common form of liver cance...
Publication Info
- Year
- 2004
- Type
- article
- Volume
- 24
- Issue
- 1
- Pages
- 1-10
- Citations
- 86
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
86
OpenAlex
Cite This
Erica Brittain,
Daphne Lin
(2004).
A comparison of intent-to-treat and per-protocol results in antibiotic non-inferiority trials.
Statistics in Medicine
, 24
(1)
, 1-10.
https://doi.org/10.1002/sim.1934
Identifiers
- DOI
- 10.1002/sim.1934